Mirella S Vredenbregt-van den Berg
Overview
Explore the profile of Mirella S Vredenbregt-van den Berg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
269
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Utomo W, Janmaat V, Verhaar A, Cros J, Levy P, Ruszniewski P, et al.
Am J Cancer Res
. 2016 Sep;
6(8):1837-41.
PMID: 27648370
Identification of pancreatic cysts with malignant potential is important to prevent pancreatic cancer development. Integrity of cell free DNA (cfDNA) has been described as tumor biomarker, but its potential for...
2.
Salih M, Fenton R, Knipscheer J, Janssen J, den Berg M, Jenster G, et al.
Am J Physiol Renal Physiol
. 2016 Jan;
310(8):F796-F801.
PMID: 26823283
Although nanosized urinary extracellular vesicles (uEVs) are increasingly used for biomarker discovery, their isolation currently relies on time-consuming techniques hindering high-throughput application. To navigate this problem, we designed an immunoassay...
3.
Duijvesz D, Versluis C, van der Fels C, den Berg M, Leivo J, Peltola M, et al.
Int J Cancer
. 2015 Jul;
137(12):2869-78.
PMID: 26139298
Extracellular vesicles (including the subclass exosomes) secreted by cells contain specific proteins and RNA that could be of interest in determining new markers. Isolation/characterization of PCa-derived exosomes from bodily fluids...
4.
Rodriguez-Blanco G, Burgers P, Dekker L, den Berg M, IJzermans J, Schenk-Braat E, et al.
Clin Biochem
. 2014 May;
47(13-14):1347-8.
PMID: 24833358
No abstract available.
5.
Duijvesz D, Burnum-Johnson K, Gritsenko M, Hoogland A, den Berg M, Willemsen R, et al.
PLoS One
. 2014 Jan;
8(12):e82589.
PMID: 24391718
Background: Current markers for prostate cancer, such as PSA lack specificity. Therefore, novel biomarkers are needed. Unfortunately, the complexity of body fluids often hampers biomarker discovery. An attractive alternative approach...
6.
Larne O, Martens-Uzunova E, Hagman Z, Edsjo A, Lippolis G, den Berg M, et al.
Int J Cancer
. 2012 Nov;
132(12):2867-75.
PMID: 23184647
Today, the majority of prostate tumors are detected at early stages with uncertain prognosis. Therefore, we set out to identify early predictive markers of prostate cancer with aggressive progression characteristics....